Article
Immunology
Stephen I. Pelton, Joaquin F. Mould-Quevedo, Van Hung Nguyen
Summary: In this study, the potential impact of egg-based quadrivalent influenza vaccine (QIVe) or adjuvanted QIV (aQIV) on hospitalizations and mortality in adults aged 65 and older with underlying chronic conditions was modeled. The use of aQIV was found to prevent more hospitalizations and deaths compared to QIVe, indicating its effectiveness in preventing severe influenza-related complications and exacerbation of chronic diseases.
Article
Cardiac & Cardiovascular Systems
Henrique Andrade R. Fonseca, Remo Holanda M. Furtado, Andre Zimerman, Pedro A. Lemos, Marcelo Franken, Frederico Monfardini, Rodrigo P. Pedrosa, Rodrigo de Lemos S. Patriota, Luiz Carlos S. Passos, Frederico Toledo C. Dall'Orto, Conrado R. Hoffmann Filho, Bruno Ramos Nascimento, Felipe A. Baldissera, Cesar Augusto C. Pereira, Paulo Ricardo A. Caramori, Pedro Beraldo de Andrade, Carlos Esteves, Elke Ferreira Salim, Jefferson Henrique da Silva, Izabela Chave Pedro, Mariana Castaldi R. Silva, Ewerton Hernandes de Pedri, Ana Carla R. D. Carioca, Luciana Pereira A. de Piano, Camila Santos N. Albuquerque, Diogo D. F. Moia, Roberta Grazzielli R. A. P. Momesso, Felipe P. Machado, Lucas P. Damiani, Ronaldo Vicente P. Soares, Guilherme P. Schettino, Luiz Rizzo, Jose Carlos Nicolau, Otavio Berwanger
Summary: This study aimed to evaluate whether double-dose influenza vaccination during hospitalization for acute coronary syndrome (ACS) would further reduce the risk of major cardiopulmonary events. The results showed that double-dose influenza vaccination before discharge did not reduce cardiopulmonary outcomes compared with standard-dose vaccination in the outpatient setting.
EUROPEAN HEART JOURNAL
(2022)
Review
Immunology
Christopher Gupta, Anjali Sachdeva, Jigish Khamar, Cecilia Bu, Jessica Bartoszko, Mark Loeb
Summary: Influenza vaccination appears to reduce adverse cardiovascular events in heart failure patients, although the certainty of the evidence is low or very low. Rigorous randomized controlled trial evidence is needed to further examine the protective effect of the influenza vaccine.
Article
Immunology
Mar Fornaguera, Oleguer Pares-Badell, Ingrid Carbones-Fargas, Cristina Andres, Jose Angel Rodrigo-Pendas, Blanca Borras-Bermejo, Lluis Armadans-Gil, Gabriela Tejada, David Guananga, Marti Vivet-Escale, Arnau Penalver-Pinol, Irene Torrecilla-Martinez, Arnau del Oso, Xavier Martinez-Gomez, Andres Anton, Susana Otero-Romero
Summary: This study aimed to estimate the influenza vaccine effectiveness against hospitalization and its determinants in a Spanish tertiary hospital in the 2021/22 season. The results showed non-significant vaccine effectiveness for this season.
Article
Immunology
Jill M. Ferdinands, Manjusha Gaglani, Emily T. Martin, Arnold S. Monto, Donald Middleton, Fernanda Silveira, Helen K. Talbot, Richard Zimmerman, Manish Patel
Summary: The effectiveness of influenza vaccine decreases with time since vaccination, with an absolute decline of about 8%-9% per month postvaccination.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Endocrinology & Metabolism
Chao-Shun Lin, Chuen-Chau Chang, Chun-Chieh Yeh, Yi-Cheng Chang, Ta-Liang Chen, Chien-Chang Liao
Summary: This study found that influenza vaccination in patients with diabetes can reduce the risks of complications and mortality during hospitalization, especially in patients with poor diabetes control and other diabetes-related comorbidities.
DIABETES RESEARCH AND CLINICAL PRACTICE
(2022)
Review
Immunology
Nicki L. Boddington, Isabelle Pearson, Heather Whitaker, Punam Mangtani, Richard G. Pebody
Summary: This systematic review found that the effectiveness of influenza vaccine against hospitalization in children varies by influenza subtype and vaccine type, with an overall seasonal IVE of 53.3%. IVE was highest against influenza A/H1N1pdm09 and lowest against influenza A/H3N2.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Immunology
Emily T. Martin, Caroline Cheng, Joshua G. Petrie, Elif Alyanak, Manjusha Gaglani, Donald B. Middleton, Shekhar Ghamande, Fernanda P. Silveira, Kempapura Murthy, Richard K. Zimmerman, Arnold S. Monto, Christopher Trabue, H. Keipp Talbot, Jill M. Ferdinands
Summary: The study evaluated the vaccine effectiveness against A(H3N2) during the 2016-2017 and 2017-2018 influenza seasons, finding relatively low effectiveness against the A(H3N2) vaccine virus, especially A/Hong Kong/4801/2014. This suggests ongoing changes in H3N2 antigenic epitopes may impact the vaccine efficacy.
JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Immunology
Mark W. Tenforde, H. Keipp Talbot, Christopher H. Trabue, Manjusha Gaglani, Tresa M. McNeal, Arnold S. Monto, Emily T. Martin, Richard K. Zimmerman, Fernanda P. Silveira, Donald B. Middleton, Samantha M. Olson, Rebecca J. Garten Kondor, John R. Barnes, Jill M. Ferdinands, Manish M. Patel
Summary: This study evaluated the effectiveness of the 2019-2020 influenza vaccine against influenza-associated hospitalization in the United States, showing a 41% reduction in risk of hospitalized influenza illness. Among the two major A(H1N1)pdmO9 subgroups, one subgroup had a vaccine effectiveness of 59%, while no effectiveness was observed in the other subgroup.
JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Immunology
Christopher A. Czaja, Myles G. Cockburn, Kathryn Colborn, Lisa Miller, Deborah S. K. Thomas, Rachel K. Herlihy, Nisha Alden, Eric A. F. Simoes
Summary: The study found that neighborhoods in Denver with higher rates of adult hospitalizations due to laboratory-confirmed influenza had lower coverage of influenza vaccine among adults. Overall vaccine coverage was low, and hospitalization rates were associated with demographic and socioeconomic characteristics. Active immunization strategies in at-risk neighborhoods may be necessary to address disparities in influenza hospitalization rates.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Immunology
Joshua D. Doyle, Lauren Beacham, Emily T. Martin, H. Keipp Talbot, Arnold Monto, Manjusha Gaglani, Donald B. Middleton, Fernanda P. Silveira, Richard K. Zimmerman, Elif Alyanak, Emily R. Smith, Brendan L. Flannery, Melissa Rolfes, Jill M. Ferdinands
Summary: The study found that during two US influenza seasons, the effectiveness of high-dose influenza vaccine for preventing influenza hospitalizations in adults aged >= 65 years was low to moderate, with high-dose vaccine offering greater effectiveness compared to standard-dose vaccine. None of these findings were statistically significant.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Immunology
Mark W. Tenforde, Jessie Chung, Emily R. Smith, H. Keipp Talbot, Christopher H. Trabue, Richard K. Zimmerman, Fernanda P. Silveira, Manjusha Gaglani, Kempapura Murthy, Arnold S. Monto, Emily T. Martin, Huong Q. McLean, Edward A. Belongia, Lisa A. Jackson, Michael L. Jackson, Jill M. Ferdinands, Brendan Flannery, Manish M. Patel
Summary: This study compared the effectiveness of influenza vaccination between inpatient and outpatient networks in the US, finding that inpatients were older and had more high-risk conditions than outpatients. The overall vaccine effectiveness across seasons was 31% for outpatients and 36% for inpatients, with some differences observed in strain-specific VE between the two groups.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Immunology
Jill M. Ferdinands, Manjusha Gaglani, Shekhar Ghamande, Emily T. Martin, Donald Middleton, Arnold S. Monto, Fernanda Silveira, Helen K. Talbot, Richard Zimmerman, Emily R. Smith, Manish Patel
Summary: The study estimated vaccine effectiveness for prevention of influenza-associated hospitalizations in adults during the 2018-2019 influenza season. The results showed positive effectiveness against influenza A(H1N1)pdm09 but no protection against influenza A(H3N2), with significant differences by age group noted.
JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Immunology
Richard K. Zimmerman, Mary Patricia Nowalk, Klancie Dauer, Lloyd Clarke, Jonathan M. Raviotta, G. K. Balasubramani
Summary: This study conducted a test-negative case control study and found that recombinant influenza vaccine (RIV4) had better effectiveness in preventing influenza hospitalization compared to standard dose vaccines (SD-IIV4). The results showed that the relative vaccine effectiveness (rVE) of RIV4 was significant among younger adults aged 18-64.
Article
Immunology
Hannah Chung, Sarah A. Buchan, Aaron Campigotto, Michael A. Campitelli, Natasha S. Crowcroft, Vinita Dubey, Jonathan B. Gubbay, Timothy Karnauchow, Kevin Katz, Allison J. McGeer, J. Dayre McNally, Samira Mubareka, Michelle Murti, David C. Richardson, Laura C. Rosella, Kevin L. Schwartz, Marek Smieja, George Zahariadis, Jeffrey C. Kwong
Summary: This study estimated the effectiveness of influenza vaccine against mortality in older adults following laboratory-confirmed influenza in Ontario, Canada. The results showed that the vaccine had a significant impact on reducing all-cause mortality, especially during the 2014-2015 influenza season. Factors such as influenza subtype and COPD also played a role in mortality outcomes.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Urology & Nephrology
I-Kuan Wang, Tsung-Hsun Tsai, Yi-Chih Hung, Tzu-Yuan Wang, Tzung-Hai Yen, Cheng-Li Lin, Fung-Chang Sung
INTERNATIONAL UROLOGY AND NEPHROLOGY
(2019)
Article
Urology & Nephrology
Shu-Ting Chang, Yu-Ting Wang, Yi-Chou Hou, I-Kuan Wang, Hsiang-Hsi Hong, Cheng-Hao Weng, Wen-Hung Huang, Ching-Wei Hsu, Tzung-Hai Yen
Article
Environmental Sciences
Chern-Horng Lee, Sen-Yung Hsieh, Wen-Hung Huang, I-Kuan Wang, Tzung-Hai Yen
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2019)
Article
Urology & Nephrology
Ching-Wei Hsu, Cheng-Hao Weng, Cheng-Chia Lee, Tzung-Hai Yen, Wen-Hung Huang
Article
Pharmacology & Pharmacy
Yun-Shiuan O. Hsu, I-Wen Wu, Shang-Hung Chang, Cheng-Chia Lee, Chung-Ying Tsai, Chan-Yu Lin, Wan-Ting Lin, Yu-Tung Huang, Chao-Yi Wu, George Kuo, Chih-Yen Hsiao, Hsing-Lin Lin, Chih-Chao Yang, Tzung-Hai Yen, Yung-Chang Chen, Cheng-Chieh Hung, Ya-Chong Tian, Chang-Fu Kuo, Chih-Wei Yang, Gerard F. Anderson, Huang-Yu Yang
CLINICAL PHARMACOLOGY & THERAPEUTICS
(2020)
Article
Clinical Neurology
I-K Wang, T-H Yen, Y-C Guo, Y. Sun, L-M Lien, W-L Chang, P-L Chen, Y-C Yang, F-C Sung, C. Y. Hsu
EUROPEAN JOURNAL OF NEUROLOGY
(2020)
Article
Toxicology
H-F Liu, C-H Ku, S-S Chang, C-M Chang, I-K Wang, H-Y Yang, C-H Weng, W-H Huang, C-W Hsu, T-H Yen
HUMAN & EXPERIMENTAL TOXICOLOGY
(2020)
Article
Chemistry, Multidisciplinary
Ryuya Hiraoka, Kento Kuwahara, Yun-Chiao Wen, Tzung-Hai Yen, Yuki Hiruta, Chao-Min Cheng, Daniel Citterio
Article
Medicine, General & Internal
Yi-Chou Hou, Yu-Ming Fan, Ya-Ching Huang, Ruei-Ming Chen, Cheng-Hsu Wang, Yi-Te Lin, Tzung-Hai Yen, Kuo-Cheng Lu, Yuh-Feng Lin
JOURNAL OF CLINICAL MEDICINE
(2020)
Article
Biophysics
Hou-Chun Huang, Wey-Ran Lin, Siew-Na Lim, Chau-Ting Yeh, Tzung-Hai Yen, Malcolm R. Alison, Chi-Shuo Chen
COLLOIDS AND SURFACES B-BIOINTERFACES
(2020)
Article
Health Care Sciences & Services
Pei-Ching Chang, Chia-Lin Hsu, Shao-Yu Tai, Aileen Tsai, I-Kuan Wang, Cheng-Hao Weng, Wen-Hung Huang, Ching-Wei Hsu, Tzung-Hai Yen
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE
(2020)
Article
Urology & Nephrology
Wen-Hung Huang, Ching-Chih Hu, Tzung-Hai Yen, Ching-Wei Hsu, Cheng-Hao Weng
Article
Oncology
Hsiang-Hsi Hong, Adrienne Hong, Chun-Chieh Wang, E-Wen Huang, Cheng-Cheng Chiang, Tzung-Hai Yen, Yi-Fang Huang
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH
(2019)
Article
Urology & Nephrology
Chih-Wei Chiu, Tsung-Hsun Tsai, Cheng-Li Lin, Tzung-Hai Yen, I-Kuan Wang, Chi-Yuan Li
Article
Clinical Neurology
Wei-Sheng Yang, Tzung-Hai Yen, Yeong-Yuh Juang, Shwu-Hua Lee, Bi-Hwa Wang, Chin-Pang Lee
NEUROPSYCHIATRIC DISEASE AND TREATMENT
(2019)